Richard D. Truesdell, Jr.
Lawyers
Filters
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Hertz $500 million senior notes offering and concurrent consent solicitations
We advised Hertz on the transactions
Datadog $1 billion convertible notes offering and capped call transactions
The 0% convertible senior notes are due 2029
Ventas public offering of 10.6 million shares
We advised Ventas on the SEC-registered public offering
Marsh McLennan $7.25 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Joby Aviation $232.3 million stock offering
The shares are listed on the New York Stock Exchange
MBX Biosciences $188 million IPO
The shares are listed on the Nasdaq Global Select Market
W.W. Grainger $500 million notes offering
The investment-grade notes are due 2034
Ventas $550 million senior notes offering
We advised Ventas on its investment-grade debt offering
Automatic Data Processing $1 billion notes offering
We advised ADP on an investment-grade notes offering